These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2079566)

  • 1. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.
    Fevery J; Elewaut A; Michielsen P; Nevens F; Van Eyken P; Adler M; Desmet V
    J Hepatol; 1990; 11 Suppl 1():S108-12. PubMed ID: 2079566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis.
    Perez V; Tanno H; Villamil F; Fay O
    J Hepatol; 1990; 11 Suppl 1():S113-7. PubMed ID: 2079567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
    Perez V; Findor J; Tanno H; Sordá J
    Gut; 1993; 34(2 Suppl):S91-4. PubMed ID: 8314497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group.
    Zarski JP; Causse X; Cohard M; Cougnard J; Trepo C
    J Hepatol; 1994 Jun; 20(6):735-41. PubMed ID: 7930473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver.
    Reichen J; Bianchi L; Frei PC; Malé PJ; Lavanchy D; Schmid M
    J Hepatol; 1994 Feb; 20(2):168-74. PubMed ID: 8006396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
    Lok AS; Wu PC; Lai CL; Lau JY; Leung EK; Wong LS; Ma OC; Lauder IJ; Ng CP; Chung HT
    Gastroenterology; 1992 Jun; 102(6):2091-7. PubMed ID: 1587429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
    S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
    Lin R; Roach E; Zimmerman M; Strasser S; Farrell GC
    J Hepatol; 1995 Nov; 23(5):487-96. PubMed ID: 8583134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
    Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
    J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel AP
    J Hepatol; 1990; 11 Suppl 1():S126-8. PubMed ID: 2079569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
    Utili R; Sagnelli E; Gaeta GB; Galanti B; Nardiello S; Felaco FM; Pasquale G; Marrone A; Aprea L; Pizzella T
    J Hepatol; 1994 Feb; 20(2):163-7. PubMed ID: 8006395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-interferon treatment in Chinese patients with chronic hepatitis B.
    Lok AS; Lai CL; Wu PC; Lau JY; Leung EK; Wong LS; Fung YL
    J Hepatol; 1990; 11 Suppl 1():S121-5. PubMed ID: 2079568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial.
    McHutchison JG; Ponnudurai R; Bylund DL; Anguiano A; Pockros PJ; Mondala T; Wilkes LB
    J Clin Gastroenterol; 2001 Feb; 32(2):133-7. PubMed ID: 11205648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial.
    Utili R; Sagnelli E; Giusti G; Ruggiero G; Piccinino F; Galanti B; Adinolfi LE; Aprea L; Cesaro G; Digilio L
    Arch Virol Suppl; 1992; 4():277-80. PubMed ID: 1450701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.